Post-approval studies (Phase 4)Looking for participantsNCT05906576
What this trial is testing
Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients
Who this might be right for
Crohn Disease
Taizhou Mabtech Pharmaceutical Co.,Ltd 30